This multicenter retrospective study was registered with the Chinese Clinical Trial Registry (ChiCTR), a primary registry within the WHO Registry Network. The registration was completed on January 19, 2025 (Registration number: ChiCTR2400080059), with a predefined target of enrolling at least 150 cases.
Wang et al. (Tue,) studied this question.